Rubius Therapeutics Pink Sheet Forecast - Polynomial Regression
| RUBYDelisted Stock | USD 0.08 0.02 17.00% |
The Polynomial Regression forecasted value of Rubius Therapeutics on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.02 and the sum of the absolute errors of 1.50. Rubius Pink Sheet Forecast is based on your current time horizon.
Rubius |
Rubius Therapeutics Polynomial Regression Price Forecast For the 28th of November
Given 90 days horizon, the Polynomial Regression forecasted value of Rubius Therapeutics on the next trading day is expected to be 0.03 with a mean absolute deviation of 0.02, mean absolute percentage error of 0.0009, and the sum of the absolute errors of 1.50.Please note that although there have been many attempts to predict Rubius Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Rubius Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Rubius Therapeutics Pink Sheet Forecast Pattern
| Backtest Rubius Therapeutics | Rubius Therapeutics Price Prediction | Buy or Sell Advice |
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Polynomial Regression forecasting method's relative quality and the estimations of the prediction error of Rubius Therapeutics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Rubius Therapeutics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.0835 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 0.0246 |
| MAPE | Mean absolute percentage error | 0.1343 |
| SAE | Sum of the absolute errors | 1.498 |
Predictive Modules for Rubius Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Rubius Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Rubius Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Rubius Therapeutics pink sheet to make a market-neutral strategy. Peer analysis of Rubius Therapeutics could also be used in its relative valuation, which is a method of valuing Rubius Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Rubius Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Rubius Therapeutics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Rubius Therapeutics shares will generate the highest return on investment. By undertsting and applying Rubius Therapeutics pink sheet market strength indicators, traders can identify Rubius Therapeutics entry and exit signals to maximize returns.
Rubius Therapeutics Risk Indicators
The analysis of Rubius Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Rubius Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting rubius pink sheet prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 9.12 | |||
| Standard Deviation | 13.32 | |||
| Variance | 177.53 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Commodity Directory module to find actively traded commodities issued by global exchanges.
Other Consideration for investing in Rubius Pink Sheet
If you are still planning to invest in Rubius Therapeutics check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Rubius Therapeutics' history and understand the potential risks before investing.
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |